MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging

Acad Radiol. 1996 Aug:3 Suppl 2:S356-8. doi: 10.1016/s1076-6332(96)80583-6.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Chelating Agents* / pharmacokinetics
  • Chelating Agents* / toxicity
  • Contrast Media / administration & dosage*
  • Contrast Media / pharmacokinetics
  • Contrast Media / toxicity
  • Drug Combinations
  • Gadolinium DTPA
  • Gadolinium* / pharmacokinetics
  • Gadolinium* / toxicity
  • Half-Life
  • Haplorhini
  • Humans
  • Injections, Intravenous
  • Magnetic Resonance Angiography*
  • Meglumine / pharmacokinetics
  • Meglumine / toxicity
  • Metabolic Clearance Rate / physiology
  • Organometallic Compounds / pharmacokinetics
  • Organometallic Compounds / toxicity
  • Pentetic Acid / analogs & derivatives
  • Pentetic Acid / pharmacokinetics
  • Pentetic Acid / toxicity
  • Protein Binding / physiology
  • Rabbits
  • Rats
  • Serum Albumin / metabolism
  • Species Specificity

Substances

  • Chelating Agents
  • Contrast Media
  • Drug Combinations
  • Organometallic Compounds
  • Serum Albumin
  • Meglumine
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA